[1] |
Delano MJ, Ward PA. Sepsis-induced immune dysfunc-tion: Can immune therapies reduce mortality[J]. J Clin Invest, 2016,126:23-31.
|
[2] |
Raphael I, Nalawade S, Eagar TN, et al. T cell subsets and their signature cytokines in autoimmune and inflammatory diseases[J]. Cytokine, 2015,74:5-17.
|
[3] |
Gupta DL, Bhoi S, Mohan T, et al. Coexistence of Th1/Th2 and Th17/Treg imbalances in patients with post traumatic sepsis[J]. Cytokine, 2016,88:214-221.
|
[4] |
Joller N, Kuchroo VK. Tim-3, Lag-3, and TIGIT[J]. Curr Top Microbiol Immunol, 2017, 10:127-156.
|
[5] |
Johannes L, Jacob R, Leffler H. Galectins at a glance[J]. J Cell Sci, 2018,131-140.
|
[6] |
Ungerer C, Quade-Lyssy P, Radeke HH, et al. Galectin-9 is a suppressor of T and B cells and predicts the immune modulatory potential of mesenchymal stromal cell preparations[J]. Stem Cells Dev, 2014,23:755-766.
|
[7] |
Emira B, Hamidreza MA. “Do we know Jack” about JAK? A closer look at JAK/STAT signaling pathway[J]. Front Oncol, 2018, 31;287-307.
|
[8] |
Bernd G, Viktoria M. Jak Stat signaling and cancer: opportunities, benefits and side effects of targeted inhibition[J]. Mol Cell Endocrinol, 2017,451:1-14.
|
[9] |
Charles JM. The role of the JAK/STAT signal pathway in rheumatoid arthritis[J]. Ther Adv Musculoskelet Dis, 2018, 10:117-127
|
[10] |
Bu M, Shen Y, Seeger WL, et al. Ovarian carcinoma-infiltrating regulatory T cells were more potent suppressors of CD8(+) T cell inflammation than their peripheral counterparts, a function dependent on TIM3 expression[J]. Tumour Biol, 2016,37:3949-3956.
|
[11] |
Madireddi S, Eun SY, Lee SW, et al. Galectin-9 controls the therapeutic activity of 4-1BB-targeting antibodies[J]. J Exp Med, 2014,211:1433-1448.
|
[12] |
曾放, 刘顺, 孙科明, 等. Tim-3/Gal-9通路在免疫相关疾病中的研究进展[J]. 医学综述, 2016, 22:1044-1047
|
[13] |
Wherry EJ, Kurachi M. Molecular and cellular insights into T cell exhaustion[J]. Nat Rev Immunol, 2015, 15:486-499.
|
[14] |
Cho JL, Roche MI, Sandall B, et al. Enhanced Tim3 activity improves survival after influenza infection[J]. J Immunol, 2012,189:2879-2889.
|
[15] |
Moodley YP, Misso NL, Scaffidi AK. Inverse effects of interleukin-6 on apoptosis of fibroblasts from pulmonary fibrosis and normal lungs[J]. Am J Respir Cell Mol Biol, 2003, 29:490-498.
|